Sunitinib-Associated Acute Pancreatitis: A Case Report

Eryilmaz M. K., Musri F. Y., Salim D. K., Tazegul G., COŞKUN H. Ş.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, cilt.1, sa.2, ss.115-117, 2017 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 1 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.14744/ejmo.2017.10820
  • Dergi Adı: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.115-117
  • Anahtar Kelimeler: Pancreatitis, renal cell carcinoma, sunitinib
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Sunitinib is a multikinase inhibitor used for the treatment of metastatic renal cell carcinoma. Acute pancreatitis associated with sunitinib is rare. Presently described is a case of a 79-year-old man with metastatic renal cell carcinoma who developed acute pancreatitis following the initiation sunitinib treatment. The development of acute pancreatitis secondary to sunitinib should be considered in patients presenting with abdominal pain after the administration of sunitinib.